Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A plus intensive physiotherapy versus intensive physiotherapy alone in children with spastic cerebral palsy
NL-OMON27016Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in spastic cerebral palsy (2 arms), sponsored by Erasmus MC. Primary endpoints: Functional health status, Health-related quality of life and 4 more. Planned start Jul 2009; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
spastic cerebral palsy
Beyond the preview
Go deeper on NL-OMON27016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27016.